Alexander Moran1, Ayden Scheim2, Carrie Lyons3, Benjamin Liestman3, Fatou Drame4, Sosthenes Ketende3, Daouda Diouf5, Ibrahima Ba5, Rebecca Ezouatchi5, Amara Bamba5, Abo Kouame6, Stefan Baral3. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Center for Public Health and Human Rights, Baltimore, MD. Electronic address: alexmoran@g.ucla.edu. 2. Department of Epidemiology and Biostatistics, Drexel University Dornsife School of Public Health, Philadelphia, PA. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Center for Public Health and Human Rights, Baltimore, MD. 4. Department of Geography, Gaston Berger University, School of Social Sciences, Senegal; Enda Santé, Dakar, Senegal. 5. Enda Santé, Dakar, Senegal. 6. Programme National de Lutte Contre le SIDA, Ministere de la Lutte Contre Le SIDA, Abidjan, Republic of Côte d'Ivoire.
Abstract
PURPOSE: HIV prevalence has been previously estimated among cisgender men who have sex with men (MSM) in Côte d'Ivoire; however, limited data exist relating to the role of social cohesion and gender identity within this population. This study aims to examine these factors as risk determinants of HIV among MSM in Côte d'Ivoire. METHODS: We conducted a cross-sectional study using respondent-driven sampling for recruitment with a structured sociobehavioral instrument and testing for HIV. After respondent-driven sampling adjustment, chi-squared tests and bivariate logistic regression and multivariate logistic regression analyses were performed to characterize social and identity-based risk determinants of biologically confirmed prevalent HIV infection. RESULTS: HIV prevalence was 11.2% (n = 146/1301). Transgender woman identity was associated with higher odds of HIV compared with cisgender MSM (aOR = 3.4, 95% CI [2.0-5.8], P < .001). Having a combined social cohesion score of medium (aOR = 0.4, 95% CI [0.2-0.8], P < .01) or high (aOR = 0.2, 95% CI [0.1-0.3], P < .001) was associated with lower odds of HIV compared with a low score. CONCLUSION: These data suggest that social cohesion is a determinant of prevalent HIV infection in Côte d'Ivoire among gay men, other cisgender MSM, and transgender women. The differences in HIV burden and social cohesion between transgender women and cisgender MSM highlight the need to better target the diversity of people traditionally included in the MSM umbrella to ensure comprehensive HIV prevention and treatment interventions.
PURPOSE: HIV prevalence has been previously estimated among cisgender men who have sex with men (MSM) in Côte d'Ivoire; however, limited data exist relating to the role of social cohesion and gender identity within this population. This study aims to examine these factors as risk determinants of HIV among MSM in Côte d'Ivoire. METHODS: We conducted a cross-sectional study using respondent-driven sampling for recruitment with a structured sociobehavioral instrument and testing for HIV. After respondent-driven sampling adjustment, chi-squared tests and bivariate logistic regression and multivariate logistic regression analyses were performed to characterize social and identity-based risk determinants of biologically confirmed prevalent HIV infection. RESULTS: HIV prevalence was 11.2% (n = 146/1301). Transgender woman identity was associated with higher odds of HIV compared with cisgender MSM (aOR = 3.4, 95% CI [2.0-5.8], P < .001). Having a combined social cohesion score of medium (aOR = 0.4, 95% CI [0.2-0.8], P < .01) or high (aOR = 0.2, 95% CI [0.1-0.3], P < .001) was associated with lower odds of HIV compared with a low score. CONCLUSION: These data suggest that social cohesion is a determinant of prevalent HIV infection in Côte d'Ivoire among gay men, other cisgender MSM, and transgender women. The differences in HIV burden and social cohesion between transgender women and cisgender MSM highlight the need to better target the diversity of people traditionally included in the MSM umbrella to ensure comprehensive HIV prevention and treatment interventions.
Authors: Paul M Pronyk; Trudy Harpham; Linda A Morison; James R Hargreaves; Julia C Kim; Godfrey Phetla; Charlotte H Watts; John D Porter Journal: Soc Sci Med Date: 2008-03-04 Impact factor: 4.634
Authors: Rhoda K Wanyenze; Geofrey Musinguzi; Joseph K B Matovu; Juliet Kiguli; Fred Nuwaha; Geoffrey Mujisha; Joshua Musinguzi; Jim Arinaitwe; Glenn J Wagner Journal: PLoS One Date: 2016-01-25 Impact factor: 3.240
Authors: Shauna Stahlman; Travis Howard Sanchez; Patrick Sean Sullivan; Sosthenes Ketende; Carrie Lyons; Manhattan E Charurat; Fatou Maria Drame; Daouda Diouf; Rebecca Ezouatchi; Seni Kouanda; Simplice Anato; Tampose Mothopeng; Zandile Mnisi; Stefan David Baral Journal: JMIR Public Health Surveill Date: 2016-07-26
Authors: Tonia Poteat; Benjamin Ackerman; Daouda Diouf; Nuha Ceesay; Tampose Mothopeng; Ky-Zerbo Odette; Seni Kouanda; Henri Gautier Ouedraogo; Anato Simplice; Abo Kouame; Zandile Mnisi; Gift Trapence; L Leigh Ann van der Merwe; Vicente Jumbe; Stefan Baral Journal: PLoS Med Date: 2017-11-07 Impact factor: 11.069
Authors: John Mark Wiginton; Sarah M Murray; Ohemaa Poku; Jura Augustinavicius; Kevon-Mark Phillip Jackman; Jeremy Kane; Serge C Billong; Daouda Diouf; Ibrahima Ba; Tampose Mothopeng; Iliassou Mfochive Njindam; Gnilane Turpin; Ubald Tamoufe; Bhekie Sithole; Maria Zlotorzynska; Travis H Sanchez; Stefan D Baral Journal: BMC Public Health Date: 2021-12-03 Impact factor: 3.295
Authors: Sophia S Miller; Joanne E Mantell; Lauren E Parmley; Godfrey Musuka; Innocent Chingombe; Munyaradzi Mapingure; John H Rogers; Yingfeng Wu; Avi J Hakim; Owen Mugurungi; Chesterfield Samba; Tiffany G Harris Journal: AIDS Behav Date: 2022-03-18
Authors: Hang Lyu; Yi Zhou; Wencan Dai; Shihan Zhen; Shanzi Huang; Lanlan Zhou; Liqun Huang; Weiming Tang Journal: Front Public Health Date: 2021-12-09